Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysis
| Autor: | Logothetis E, H. Tzanatos-Exarchou, D Koutsicos, Basil Agroyannis, H Yatzidis, Kaya S, Frangos-Plemenos M, Sarris E |
|---|---|
| Rok vydání: | 1987 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment 030232 urology & nephrology Biomedical Engineering Medicine (miscellaneous) Bioengineering 030204 cardiovascular system & hematology Gastroenterology Biomaterials 03 medical and health sciences 0302 clinical medicine Renal Dialysis Internal medicine medicine Humans In patient Chronic hemodialysis Aged Uremia Ferroxidase I biology business.industry Healthy subjects Ceruloplasmin General Medicine Maintenance hemodialysis Middle Aged Conservative treatment biology.protein Female Hemodialysis business Oxidoreductases |
| Zdroj: | The International journal of artificial organs. 10(3) |
| ISSN: | 0391-3988 |
| Popis: | Serum ferroxidase I (ceruloplasmin) and ferroxidase II activities were studied in 49 uremic patients under conservative treatment, in 79 patients undergoing hemodialysis and in 56 healthy subjects, as controls. Ferroxidase I was significantly higher in both groups of patients. Ferroxidase II was significantly elevated only in patients undergoing chronic hemodialysis. The cause of this difference is not clear, but seems to be of considerable interest. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|